A shared formulation design space reveals poly(2-ethyl-2oxazoline) chain length as a determinant of lipid nanoparticle performance and relative organ distribution
Year: 2026
Type: preprint
Abstract: The interface between lipid nanoparticles (LNPs) and their biological environment represents a key determinant of biodistribution. Here, we investigated poly(2-ethyl-2oxazoline) (PEtOx)-lipids as an adaptable component of this interface and determined how polymer chain length affects LNP formulation as well as biological behavior. Rather than comparing different polymers with a single nominal formulation composition, we first mapped the pharmaceutical design space of four PEtOx-lipids containing average chain lengths of 20, 34, 49, or 71 repeating units and identified formulation conditions that supported acceptable LNP formation. This shared design space subsequently enabled the comparison of chain-length-dependent effects under pharmaceutically viable conditions. Increasing PEtOx chain length decreased the apparent hydrophobicity of the PEtOx-lipids and was associated with progressively smaller LNP diameters, lower mRNA encapsulation efficiencies, and a narrower formulation space in which predefined criteria for size, polydispersity, and mRNA loading were met concomitantly. Optimized PEtOx-LNPs mediated mRNA expression across multiple primary and human induced pluripotent stem cell-derived cell types with limited effects on cell viability. Pooled in vivo DNA barcoding of the PEtOx20-, PEtOx34-, and PEtOx49-LNPs revealed chain-length-dependent differences in relative organ barcode distribution, with shorter chains shifting relative distribution toward spleen and pancreas and away from bone marrow and liver. Together, these findings establish PEtOx chain length as an independent LNP design parameter and demonstrate a formulation-space-based strategy for comparing polymeric excipients without relying on a single predefined formulation composition.
Source: ChemRxiv
Authors: Franziska Adermann(Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing), Giorgia Gerolimetto(Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing), Caroline T. Holick(Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing), Ilayda Ates(Data curation, Formal analysis, Investigation, Methodology), Emma Steffens(Investigation, Methodology, Writing – original draft, Writing – review & editing), Ekaterina Tsarenko(Formal analysis, Investigation), Josef Kehrein(Data curation, Formal analysis, Visualization, Writing – original draft, Writing – review & editing), Julia Klüpfel(Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing), Christine Weber(Data curation, Formal analysis, Supervision, Writing – review & editing), Xiaoxuan Wang(Methodology), Marcus Gutmann(Investigation, Methodology), Markus Hafke(Investigation), Tim Ammon(Investigation), Sarah Heil(Investigation), Felix Schuster(Investigation), Barbara Fink(Investigation), Miriam A. Christlmeier(Investigation), Susanne Götze(Investigation), Lilia Espada(Investigation), Manuela Benedicic(Investigation), Tessa Lühmann(Supervision), Ivo Nischang(Methodology, Supervision, Writing – review & editing), Hans-Peter Holthoff(Funding acquisition, Resources, Supervision), Martin J. Lohse(Funding acquisition, Resources, Supervision), Martin Ungerer(Funding acquisition, Resources, Supervision), Stephanie Schubert(Funding acquisition, Resources, Supervision, Writing – review & editing), Florian A. Mann(Funding acquisition, Resources, Supervision), Ulrich S. Schubert(Funding acquisition, Resources, Supervision), Lorenz Meinel(Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7234850899
